Swiss National Bank’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Sell
107,500
-2,200
-2% -$55.1K ﹤0.01% 1839
2026
Q1
$2.74M Hold
109,700
﹤0.01% 1690
2025
Q4
$3.45M Buy
109,700
+2,500
+2% +$82.9K ﹤0.01% 1577
2025
Q3
$3.83M Buy
107,200
+7,600
+8% +$347K ﹤0.01% 1470
2025
Q2
$5.74M Hold
99,600
﹤0.01% 1209
2025
Q1
$5.8M Buy
99,600
+2,500
+3% +$171K ﹤0.01% 1178
2024
Q4
$7.82M Buy
97,100
+1,700
+2% +$145K 0.01% 1067
2024
Q3
$7.64M Buy
95,400
+5,200
+6% +$369K 0.01% 1074
2024
Q2
$5.51M Buy
90,200
+500
+0.6% +$29.7K ﹤0.01% 1216
2024
Q1
$4.43M Buy
89,700
+1,600
+2% +$76.2K ﹤0.01% 1370
2023
Q4
$3.69M Buy
88,100
+3,900
+5% +$133K ﹤0.01% 1472
2023
Q3
$2.76M Buy
84,200
+1,100
+1% +$37.5K ﹤0.01% 1640
2023
Q2
$2.94M Buy
83,100
+58,900
+243% +$1.95M ﹤0.01% 1636
2023
Q1
$687K Sell
24,200
-2,700
-10% -$95.2K ﹤0.01% 2434
2022
Q4
$1.12M Buy
26,900
+1,000
+4% +$42.9K ﹤0.01% 2286
2022
Q3
$1.07M Hold
25,900
﹤0.01% 2300
2022
Q2
$847K Buy
+25,900
New +$942K ﹤0.01% 2453

Other funds holding PRCT

Swiss National Bank's PRCT Position: Q2 2026 in Review

Swiss National Bank reduced its Procept Biorobotics (PRCT) stake by 2% in Q2 2026, selling an estimated $55.1K and leaving 107,500 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

Swiss National Bank first reported a position in PRCT in Q2 2022 and has held it in 17 quarters since. The position peaked at $7.82M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Swiss National Bank held 107,500 shares of Procept Biorobotics worth $2.43M as of Q2 2026.
  • Swiss National Bank sold 2,200 Procept Biorobotics shares in Q2 2026, an estimated $55.1K.
  • Procept Biorobotics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1839 holding.
  • Swiss National Bank first reported a position in Procept Biorobotics in Q2 2022 and has held it in 17 quarters since.
  • Swiss National Bank's Procept Biorobotics position peaked at $7.82M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.